Pharmabiz36m
Norgine submits MAA to EMA for eflornithine in high-risk neuroblastoma
Norgine submits MAA to EMA for eflornithine in high-risk neuroblastoma: Netherlands Wednesday, January 8, 2025, 17:00 Hrs [IST] Norgine, a uniquely positioned, specialty pharmaceu ...
Pharmabiz51m
No need to get anxious over HMPV virus infection, it is not dangerous like coronavirus: Experts
No need to get anxious over HMPV virus infection, it is not dangerous like coronavirus: Experts: Our Bureau, Chennai Wednesday, January 8, 2025, 16:45 Hrs [IST] Although two cases ...
Pharmabiz1h
Medanta strengthens its Renal Care Institute, appoints leading urologist Dr Sanjay Gogoi as chairman
Medanta strengthens its Renal Care Institute, appoints leading urologist Dr Sanjay Gogoi as chairman: Our Bureau, Mumbai Wednesday, January 8, 2025, 16:15 Hrs [IST] Reinforcing it ...
Pharmabiz1h
US FDA issues draft guidance on including tissue biopsies in clinical trials
US FDA issues draft guidance on including tissue biopsies in clinical trials: Maryland Wednesday, January 8, 2025, 16:00 Hrs [IST] The US Food and Drug Administration (FDA) issued ...
Pharmabiz2h
WuXi Biologics grants exclusive global rights of trispecific t-cell engager to Candid Therapeutics
WuXi Biologics grants exclusive global rights of trispecific t-cell engager to Candid Therapeutics: Shanghai Wednesday, January 8, 2025, 15:00 Hrs [IST] WuXi Biologics, a leading ...
Pharmabiz6h
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices: Maryland Wednesday, January 8, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ...
Pharmabiz7h
US FDA grants breakthrough therapy designation to GSK’s B7-H3-targeted ADC, GSK’227 to treat relapsed or refractory osteosarcoma
US FDA grants breakthrough therapy designation to GSK’s B7-H3-targeted ADC, GSK’227 to treat relapsed or refractory osteosarcoma: London, UK Wednesday, January 8, 2025, 10:00 ...
Pharmabiz8h
MTaI to host MedTekon 2025 in New Delhi on January 30
Our Bureau, New Delhi Wednesday, January 8, 2025, 09:00 Hrs [IST] Medical Technology Association of India (MTaI), which repr ...
Pharmabiz9h
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act: Shardul Nautiyal, Mumbai Wednesday, January 8, 2025, 08:00 Hrs [IST] Despit ...
Pharmabiz9h
Govt must adopt a pragmatic approach on revised Schedule M similar to US FDA compliance: Manoj Palrecha
Govt must adopt a pragmatic approach on revised Schedule M similar to US FDA compliance: Manoj Palrecha: Nandita Vijayasimha, Bengaluru Wednesday, January 8, 2025, 08:00 Hrs [IST] ...
Pharmabiz9h
TN DCA gearing up for inspection of pharma units to ensure compliance with revised Schedule M
Peethaambaran Kunnathoor, Chennai Wednesday, January 8, 2025, 08:00 Hrs [IST] ...
Pharmabiz9h
CDSCO seeks industry comment on updated classification list of four medical devices categories
CDSCO seeks industry comment on updated classification list of four medical devices categories: Gireesh Babu, New Delhi Wednesday, January 8, 2025, 08:00 Hrs [IST] The Central Dru ...